Delayed cerebral thrombosis complicating pneumococcal meningitis: an autopsy study. 2018

Joo-Yeon Engelen-Lee, and Matthijs C Brouwer, and Eleonora Aronica, and Diederik van de Beek
Department of Neurology, Academic Medical Center, University of Amsterdam, Amsterdam Neuroscience, PO Box 22660, 1100 DD, Amsterdam, The Netherlands.

BACKGROUND Delayed cerebral thrombosis (DCT) is a devastating cerebrovascular complication in patients with excellent initial recovery of pneumococcal meningitis. The aetiology is unknown, but direct bacterial invasion, activation of coagulation or post-infectious immunoglobulin deposition has been suggested. METHODS We studied histopathology of 4 patients with pneumococcal meningitis complicated by DCT. Results were compared with 8 patients who died of pneumococcal meningitis without DCT and 3 non-meningitis control cases. Furthermore, we evaluated vascular immunoglobulin depositions (IgA, IgG and IgM) and the presence of pneumococcal capsules by immunofluorescence. RESULTS Patients who died after pneumococcal meningitis showed inflammation in the meninges and blood vessels with extensive infarction and thrombosis. We did not observe gross differences between DCT and non-DCT patients, except that 2 of 4 DCT patients had a basilar artery aneurysm compared to none of the non-DCT patients. We observed high density of IgM and IgG deposition in meningitis cases as compared to controls, but no difference between DCT and non-DCT patients. Immunofluorescence staining of pneumococci demonstrated the presence of bacterial capsules in the meninges of all meningitis patients, even 35 days after the initiation of antibiotic treatment. CONCLUSIONS The aetiology of DCT complicating pneumococcal meningitis seems to be of multifactorial aetiology and includes vascular inflammation, thromboembolism of large arteries and infectious intracranial aneurysms. Pneumococcal cell wall components can be observed for weeks after pneumococcal meningitis and may be a source of resurging inflammation after the initial immunosuppression by dexamethasone.

UI MeSH Term Description Entries

Related Publications

Joo-Yeon Engelen-Lee, and Matthijs C Brouwer, and Eleonora Aronica, and Diederik van de Beek
April 2022, Acta clinica Belgica,
Joo-Yeon Engelen-Lee, and Matthijs C Brouwer, and Eleonora Aronica, and Diederik van de Beek
January 2018, European journal of case reports in internal medicine,
Joo-Yeon Engelen-Lee, and Matthijs C Brouwer, and Eleonora Aronica, and Diederik van de Beek
December 2009, Neurology,
Joo-Yeon Engelen-Lee, and Matthijs C Brouwer, and Eleonora Aronica, and Diederik van de Beek
June 2023, BMC neurology,
Joo-Yeon Engelen-Lee, and Matthijs C Brouwer, and Eleonora Aronica, and Diederik van de Beek
May 1991, Archives of internal medicine,
Joo-Yeon Engelen-Lee, and Matthijs C Brouwer, and Eleonora Aronica, and Diederik van de Beek
January 1993, Postgraduate medical journal,
Joo-Yeon Engelen-Lee, and Matthijs C Brouwer, and Eleonora Aronica, and Diederik van de Beek
October 2023, Acta neurologica Belgica,
Joo-Yeon Engelen-Lee, and Matthijs C Brouwer, and Eleonora Aronica, and Diederik van de Beek
May 2013, Intensive care medicine,
Joo-Yeon Engelen-Lee, and Matthijs C Brouwer, and Eleonora Aronica, and Diederik van de Beek
August 2008, Neurology,
Copied contents to your clipboard!